Luca Santuari

This paper evaluates the Ultima Genomics UG 100 sequencing platform's ability to identify short variants, particularly in long homopolymer regions, compared to Illumina NovaSeq 6000 for clinical use.

The paper develops a method to create personalized regulatory networks for cancer patients using PDX models, integrating gene expression data and genetic algorithms with GCNs to predict treatment outcomes.

sv-channels improves SV detection precision using deep learning, outperforming GRIDSS while maintaining Manta's recall.

Seq2scFv annotates and characterizes scFv sequences from long-read sequencing data to improve antibody discovery.